Medicare Enrolled
Dr. Kenneth Delay, M.D.
Urology Physician · Columbus, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Delay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delay?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delay
Dr. Kenneth Delay is an urology physician in Columbus, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Delay performed 4,337 Medicare services across 1,462 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delay received a total of $18,578 from 39 pharmaceutical and/or device companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 22% volume in GA
$18,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,337
Medicare services
Top 22% in GA for urology physician
1,462
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~271 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,550 | $0 | $2 |
| BCG treatment for bladder cancer | 1,138 | $2 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
256 | $2 | $19 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
193 | $82 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $59 | $165 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
134 | $164 | $636 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
125 | $7 | $7 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
121 | $7 | $49 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $111 | $364 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
62 | $59 | $284 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
56 | $0 | $26 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
55 | $80 | $237 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
38 | $59 | $273 |
| Ultrasound of penis artery and vein blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis. |
36 | $78 | $626 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
33 | $64 | $228 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
30 | $528 | $2,801 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
29 | $310 | $2,184 |
| Insertion of multicomponent inflatable penile implant | 29 | $585 | $3,383 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
28 | $344 | $1,423 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
28 | $112 | $1,014 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
22 | $14 | $51 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $103 | $400 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
21 | $50 | $296 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $38 | $103 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $176 | $758 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
14 | $44 | $390 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
12 | $79 | $899 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
12 | $173 | $1,504 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $135 | $324 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
11 | $10 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
44.0% medium
54.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,578
Total received (2018-2024)
Avg $2,654/year across 7 years
Top 11% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
338
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,114 (70.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,900 (26.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$565 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$228
2023
$412
2022
$378
2021
$682
2020
$1,648
2019
$5,419
2018
$9,811
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Calyxo, Inc.
$114
Innovation Technologies Inc
$47
COLOPLAST CORP
$41
Merck Sharp & Dohme LLC
$26
Top 3 companies account for 88.5% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$5,423
BOSTON SCIENTIFIC CORPORATION
$5,031
Boston Scientific Corporation
$3,532
Astellas Pharma US Inc
$1,062
Amgen Inc.
$406
Allergan Inc.
$358
PFIZER INC.
$281
Endo Pharmaceuticals Inc.
$272
Janssen Biotech, Inc.
$266
Teleflex LLC
$149
Dendreon Pharmaceuticals LLC
$145
Allergan, Inc.
$145
TOLMAR Pharmaceuticals, Inc.
$142
AbbVie, Inc.
$133
Calyxo, Inc.
$114
AbbVie Inc.
$101
MEDIVATION FIELD SOLUTIONS LLC
$100
Bayer HealthCare Pharmaceuticals Inc.
$89
Ferring Pharmaceuticals Inc.
$84
Blue Earth Diagnostics Limited
$76
Avadel Specialty Pharmaceuticals, LLC
$76
COLOPLAST CORP
$74
Olympus America Inc.
$67
Innovation Technologies Inc
$47
Laborie Medical Technologies Corp.
$43
Axonics Modulation Technologies, Inc.
$39
Antares Pharma, Inc.
$37
KARL STORZ Endoscopy-America
$35
Myovant Sciences Inc.
$34
AstraZeneca Pharmaceuticals LP
$33
Cook Medical LLC
$31
Ambu Inc.
$28
Merck Sharp & Dohme LLC
$26
Rochester Medical Corporation
$23
DENTSPLY IH Inc.
$20
Travere Therapeutics, Inc.
$19
Medtronic, Inc.
$14
Merck Sharp & Dohme Corporation
$13
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 75.3% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS · AMS 700 CXR RTE Kit · AVEED · Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRIDION · CVAC ASPIRATION SYSTEM · Cook Medical Stents · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · GENERAL THERAPIES · GREENLIGHT · INTERSTIM · IRRISEPT · LUPRON DEPOT · LYNPARZA · LYNX · LoFric · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Noctiva · Nubeqa · ORGOVYX · PENILE & TESTICULAR RECONSTRUCTN · PROVENGE · Prolia · REZUM · SPACEOAR · SPIES CMOS VIDEO URETEROSCOPE · SUPRIS · SUTENT · SpaceOAR VUE System - 10mL · SpeediCath · THERAPIES · TITAN · TOVIAZ · Thiola · Titan · UGN Laser Capital · UROLIFT · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
10
Per 100K population
4.9
County median income
$56,622
Nearest hospital
PIEDMONT COLUMBUS REGIONAL MIDTOWN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Delay is a mixed practice specialist, with above-average Medicare volume (top 22% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Delay experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Delay performed 1,550 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delay receive payments from pharmaceutical companies?
Yes. Dr. Delay received a total of $18,578 from 39 companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delay's costs compare to other urology physicians in Columbus?
Dr. Delay's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Columbus
Browse urology physicians in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology